Pharma-Bio Serv PBSV

OTC PBSV
$0.40 -0.02 (-4.76%)
At close: Oct 15, 2026 · 4:00 PM EDT

Pharma-Bio Serv (PBSV) stock price is $0.40, down 4.76% on the day, as of Oct 15, 2026. It has a market cap of $10.99Mn and a P/E ratio of 43.70, and is classified in the Consulting industry (Industrials sector).

Key Stats
Market Cap10.99 Mn
P/E43.70
P/S1.16
Div. Yield0.00
Revenue Growth (1y) (Qtr)19.00
Add ratio to table…

About

Pharma-Bio Serv, Inc. is a Delaware corporation organized on January 14 2004 and provides technical compliance consulting services to the pharmaceutical chemical biotechnology medical devices cosmetic and food industries and allied products companies in Puerto Rico the United States Europe and Brazil. The firm operates as a regulatory affairs quality compliance and technology transfer services consulting firm with headquarters in Puerto Rico serving clients across multiple…

Read more ↓
Sectors: Industrials Healthcare Sector rationale The company's primary revenue model is based on providing technical compliance consulting, engineering project management, and process support to a broad range of industrial clients, including chemical, cosmetic, and food industries. While it heavily serves the life sciences sector (pharmaceuticals, biotech, and medical devices), which justifies a secondary sector in Healthcare, the core activity of 'technical compliance consulting' and 'engineering' for diverse manufacturing clients falls under the Industrials sector's consulting and business-facing services. Industries: Consulting Consulting Primary Pharma-Bio Serv is a consulting firm that sells professional expertise in regulatory affairs, quality compliance, and technology transfer. Its revenue is primarily generated through time and materials contracts for providing technical compliance consulting to businesses in the pharmaceutical, biotechnology, and medical device industries. Contract Research Contract Research Secondary The company provides validation, regulatory compliance, and process support services to pharmaceutical and biotechnology companies, which are core activities of contract research and development outsourcing for drug and device sponsors. Classified using BQ-MICS CIK: 0001304161

Statement Geographical Axis Breakdown of Revenue (2025)

History
Peer percentiles

How Pharma-Bio Serv ranks

Ranked against the 130 companies in Business Services58 metrics · as of Oct 16, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/E 36.4xMedian 19.9x 51st
  • P/FCFNegative free cash flow −21.7xMedian 11.8x 21st
  • P/Operating cash flowNegative operating cash flow −22.1xMedian 10.2x 13th
  • P/S 0.97xMedian 0.82x 43rd
  • P/B 0.88xMedian 2.17x 77th
  • P/Tangible book 0.88xMedian 2.90x 77th
  • EV/EBITDANegative EBITDA −6.02xMedian 11.7x 11th
  • EV/EBITNegative EBIT −3.77xMedian 16.5x 9th
  • EV/Revenue 0.06xMedian 1.11x 99th
  • EV/FCFNegative free cash flow −1.38xMedian 16.8x 1st
  • EV/Operating cash flowNegative operating cash flow −1.41xMedian 14.2x 1st
  • PEG (3Y EPS CAGR)EPS is not growing −0.81Median 0.98 Not meaningful —
Peer group

Peer Comparison

Companies in the Consulting
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 ACN Accenture plc 145.07 Bn18.621.985.14 Bn
2 CTAS Cintas Corp 84.93 Bn41.227.352.43 Bn
3 IRM Iron Mountain Inc 33.24 Bn79.404.4017.35 Bn
4 APG APi Group Corp 17.33 Bn-69.862.053.52 Bn
5 ROL Rollins Inc 15.77 Bn29.674.020.70 Bn
6 ULS UL Solutions Inc. 14.77 Bn29.244.690.30 Bn
7 ARMK Aramark 14.70 Bn38.380.746.13 Bn
8 PBSV Pharma-Bio Serv, Inc. 0.01 Bn43.701.16-